Therapeutic targets of triple-negative breast cancer: a review-Reference-Cited by-同舟云学术

Therapeutic targets of triple-negative breast cancer: a review

Published:2015-07-30 Issue:17 Volume:172 Page:4228-4237
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Jamdade Vinayak S¹,Sethi Nikunj²³,Mundhe Nitin A¹,Kumar Parveen¹,Lahkar Mangala¹⁴,Sinha Neeraj²³

Affiliation:

1. Laboratory of Molecular Pharmacology and Toxicology; Department of Pharmacology and Toxicology; National Institute of Pharmaceutical Education and Research (NIPER); Gauhati Medical College; Guwahati India

2. Academy of Scientific and Innovative Research (AcSIR); New Delhi India

3. Division of Toxicology; CSIR-Central Drug Research Institute; Lucknow India

4. Laboratory of Pharmacology; Department of Pharmacology; Gauhati Medical College; Guwahati India

Funder

National Institute of Pharmaceutical Education and Research (NIPER), Guwahati

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.13211/fullpdf

Reference72 articles.

1. Notch signaling pathway as a therapeutic target in breast cancer;Al-Hussaini;Mol Cancer Ther,2011

2. The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors;Alexander;Br J Pharmacol,2013a

3. The Concise Guide to PHARMACOLOGY 2013/14: catalytic receptors;Alexander;Br J Pharmacol,2013b

4. The Concise Guide to PHARMACOLOGY 2013/14: enzymes;Alexander;Br J Pharmacol,2013c

5. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization;Assoian;J Biol Chem,1983

Cited by 170 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning-based QSAR modeling, molecular docking, dynamics simulation studies for cytotoxicity prediction in MDA-MB231 triple-negative breast cancer cell line;Journal of Molecular Structure;2024-11

2. Prognostic and Therapeutic Implications of Cell Division Cycle 20 Homolog in Breast Cancer;Cancers;2024-07-15

3. Assessing the fiscal consequences of novel and existing treatments for triple negative breast cancer in Switzerland by applying a government perspective framework;Journal of Medical Economics;2024-07

4. Exploring the Potential of Nanomolecular Therapeutic Therapy Options, and Novel Biomarkers in Triple-negative Breast Cancer Treatment;Current Cancer Therapy Reviews;2024-06-11

5. Glyoxalase System in Breast and Ovarian Cancers: Role of MEK/ERK/SMAD1 Pathway;Biomolecules;2024-05-15